Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
94 participants
OBSERVATIONAL
2020-04-12
2021-10-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Osteopathic Support Evaluation of Fibromyalgia Patients
NCT02805673
Osteopathic Medicine in Fibromyalgia Syndrome
NCT02343237
Functional Assessment of the Patient With Fibromyalgia and Its Relation to Health: Fibromyalgia and Sarcopenia
NCT06253273
Resilience Factors and Selective Learning in Patients With Fibromyalgia
NCT04889300
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
NCT03300635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fibromyalgia
FM group was recruited at AMaR (rheumatic patients association of Piedmont) and the diagnosis of primary fibromyalgia was confirmed by the referring rheumatologist of the AMaR association.
Life Stressor Checklist Revised (LSC-R) (Appendix 1)
Evaluation of stress factor as risk factor for fibromyalgia development
Control
The control group was recruited in the same geographic area as the FM participant. The general practitioner of each individual patient certified the subject's state of good health.
Life Stressor Checklist Revised (LSC-R) (Appendix 1)
Evaluation of stress factor as risk factor for fibromyalgia development
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Life Stressor Checklist Revised (LSC-R) (Appendix 1)
Evaluation of stress factor as risk factor for fibromyalgia development
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient from Piedmont
* age between 20 and 65 years old
* inform consent
* for case group primary or secondary fibromyalgia
Exclusion Criteria
* for control group the presence of primary or secondary fibromyalgia
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Studio Osteopatico Busto Arsizio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolina Lavazza
Osteopath
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolina Lavazza, MSc
Role: STUDY_CHAIR
Accademia Italiana Medicina Osteopatica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OsteoMedical
Novara, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
230176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.